BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31324712)

  • 1. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain:
    Mansur A; Rabiner EA; Comley RA; Lewis Y; Middleton LT; Huiban M; Passchier J; Tsukada H; Gunn RN;
    J Nucl Med; 2020 Jan; 61(1):96-103. PubMed ID: 31324712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test-retest variability and reference region-based quantification of
    Mansur A; Rabiner EA; Tsukada H; Comley RA; Lewis Y; Huiban M; Passchier J; Gunn RN
    J Cereb Blood Flow Metab; 2021 Apr; 41(4):771-779. PubMed ID: 32501157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
    J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
    Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
    Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease.
    Wilson H; Pagano G; de Natale ER; Mansur A; Caminiti SP; Polychronis S; Middleton LT; Price G; Schmidt KF; Gunn RN; Rabiner EA; Politis M
    Mov Disord; 2020 Aug; 35(8):1416-1427. PubMed ID: 32347983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-Human Evaluation of
    Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE
    J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of synaptic density with [
    Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
    Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 18F-BCPP-EF for mitochondrial complex 1 imaging in the brain of conscious monkeys using PET.
    Tsukada H; Ohba H; Kanazawa M; Kakiuchi T; Harada N
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):755-63. PubMed ID: 24258008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic evaluation and test-retest reproducibility of [
    Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain.
    Harada N; Nishiyama S; Kanazawa M; Tsukada H
    J Labelled Comp Radiopharm; 2013 Sep; 56(11):553-61. PubMed ID: 24285187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and noninvasive kinetic modeling of [
    Bertoglio D; Verhaeghe J; Miranda A; Kertesz I; Cybulska K; Korat Š; Wyffels L; Stroobants S; Mrzljak L; Dominguez C; Liu L; Skinbjerg M; Munoz-Sanjuan I; Staelens S
    J Cereb Blood Flow Metab; 2020 Jun; 40(6):1351-1362. PubMed ID: 31307287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical PET Studies of [
    Thomsen MB; Schacht AC; Alstrup AKO; Jacobsen J; Lillethorup TP; Bærentzen SL; Noer O; Orlowski D; Elfving B; Müller HK; Brooks DJ; Landau AM
    Mol Imaging Biol; 2020 Oct; 22(5):1290-1300. PubMed ID: 32514885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain.
    Tsukada H; Nishiyama S; Fukumoto D; Kanazawa M; Harada N
    J Nucl Med; 2014 Mar; 55(3):473-80. PubMed ID: 24470629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and 28-day test-retest repeatability and reproducibility of [
    Tuncel H; Boellaard R; Coomans EM; de Vries EF; Glaudemans AW; Feltes PK; García DV; Verfaillie SC; Wolters EE; Sweeney SP; Ryan JM; Ivarsson M; Lynch BA; Schober P; Scheltens P; Schuit RC; Windhorst AD; De Deyn PP; van Berckel BN; Golla SS
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1338-1350. PubMed ID: 34013797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vivo evaluation of [
    Li S; Cai Z; Zhang W; Holden D; Lin SF; Finnema SJ; Shirali A; Ropchan J; Carre S; Mercier J; Carson RE; Nabulsi N; Huang Y
    Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1952-1965. PubMed ID: 31175396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic density in healthy human aging is not influenced by age or sex: a
    Michiels L; Delva A; van Aalst J; Ceccarini J; Vandenberghe W; Vandenbulcke M; Koole M; Lemmens R; Laere KV
    Neuroimage; 2021 May; 232():117877. PubMed ID: 33639258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A-Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity.
    Patel S; Knight A; Krause S; Teceno T; Tresse C; Li S; Cai Z; Gouasmat A; Carroll VM; Barret O; Gottmukkala V; Zhang W; Xiang X; Morley T; Huang Y; Passchier J
    Mol Imaging Biol; 2020 Aug; 22(4):832-841. PubMed ID: 31728839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain.
    Tsukada H; Ohba H; Nishiyama S; Kanazawa M; Kakiuchi T; Harada N
    J Cereb Blood Flow Metab; 2014 Apr; 34(4):708-14. PubMed ID: 24447952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying SV2A density and drug occupancy in the human brain using [
    Koole M; van Aalst J; Devrome M; Mertens N; Serdons K; Lacroix B; Mercier J; Sciberras D; Maguire P; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy brain aging assessed with [
    Andersen KB; Hansen AK; Knudsen K; Schacht AC; Damholdt MF; Brooks DJ; Borghammer P
    Nucl Med Biol; 2022; 112-113():52-58. PubMed ID: 35820300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.